Ursolic acid suppresses IL-6 induced C-reactive protein expression in HepG2 and protects HUVECs from injury induced by CRP

European Journal of Pharmaceutical Sciences

Volumn 45, Issue 1-2, 2012, Pages 190-194

  Lv, Yuan Yuan ^a   Jin, Yue ^a   Han, Guo Zhu ^a   Liu, Yan Xia ^a   Wu, Tao ^a   Liu, Peng ^a   Zhou, Qin ^a   Liu, Ke Xin ^a   Sun, Hui Jun ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

CRP; HepG2; HUVECs; UA; Vascular endothelial injury

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; RNA; URSOLIC ACID; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HEP G2 CELLS; HEPATOCYTES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; OSMOLAR CONCENTRATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS E; TRITERPENES; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 83655167399     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.11.002     Document Type: Article

References (33)

1. C. Cárdenas, A.R. Quesada, and M.A. Medina Effects of ursolic acid on different steps of the angiogenic process Biochem. Biophys. Res. Commun. 320 2004 402 408 (Pubitemid 38798881)
2. Y.H. Chen, S.J. Lin, Y.L. Chen, P.L. Liu, and J.W. Chen Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules Cardiovasc. Hematol. Disord. Drug Targets 6 2006 279 304
3. S. Devaraj, B. Davis, S.I. Simon, and I. Jialal CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions Am. J. Physiol. Heart Circ. Physiol. 291 2006 H1170 H1176 (Pubitemid 44343660)
4. Y. Dohi, H. Takase, K. Sato, and R. Ueda Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects Int. J. Cardiol. 115 2007 63 66 (Pubitemid 44856754)
5. J. Galle, T. Hansen-Hagge, C. Wanner, and S. Seibold Impact of oxidized low density lipoprotein on vascular cells Atherosclerosis 185 2006 219 226
6. C.K. Glass, and J.L. Witztum Atherosclerosis: the road ahead Cell 104 2001 503 516 (Pubitemid 32201946)
7. G.K. Hansson Inflammation and immune response in atherosclerosis Curr. Atheroscler. Rep. 1 1999 150 155
8. C.L. Heslop, J.J. Frohlich, and J.S. Hill Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography J. Am. Coll. Cardiol. 55 2010 1102 1109
9. I. Jialal, and S. Devaraj Role of C-reactive protein in the assessment of cardiovascular risk Am. J. Cardiol. 91 2003 200 202 (Pubitemid 36084307)
10. E. Kassi, T.G. Sourlingas, M. Spiliotaki, Z. Papoutsi, H. Pratsinis, N. Aligiannis, and P. Moutsatsou Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells Cancer Invest. 27 2009 723 733
11. D. Kawanami, K. Maemura, N. Takeda, T. Harada, T. Nojiri, T. Saito, I. Manabe, Y. Imai, and R. Nagai C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells Atherosclerosis 185 2006 39 46 (Pubitemid 43117549)
12. L. Li, N. Roumeliotis, T. Sawamura, and G. Renier C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction Circ. Res. 95 2004 877 883 (Pubitemid 39435002)
13. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874 (Pubitemid 36019640)
14. J. Liu Pharmacology of oleanolic acid and ursolic acid J. Ethnopharmacol. 49 1995 57 68 (Pubitemid 26010740)
15. H. Morawietz, N. Duerrschmidt, B. Niemann, J. Galle, T. Sawamura, and J. Holtz Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells Biochem. Biophys. Res. Commun. 284 2001 961 965 (Pubitemid 32924741)
16. R.F. Mortensen C-reactive protein, inflammation, and innate immunity Immunol. Res. 24 2001 163 176 (Pubitemid 32897076)
17. M. Nagase, J. Abe, K. Takahashi, J. Ando, S. Hirose, and T. Fujita Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene J. Biol. Chem. 273 1998 33702 33707 (Pubitemid 29005759)
18. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, T. Crowe, W.J. Sasiela, J. Tsai, J. Orazem, R.D. Magorien, C. O'Shaughnessy, and P. Ganz Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease N. Engl. J. Med. 352 2005 29 38 (Pubitemid 40075678)
19. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
20. D.J. Preiss, and N. Satta Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? Int. J. Clin. Pract. 61 2007 697 701 (Pubitemid 46449832)
21. M. Pozo, V. Castilla, C. Gutierrez, R. de Nicolás, J. Egido, and J. González-Cabrero Ursolic acid inhibits neointima formation in the rat carotid artery injury model Atherosclerosis 184 2006 53 62 (Pubitemid 41721069)
22. P.M. Ridker, C.P. Cannon, D. Morrow, N. Rifai, L.M. Rose, C.H. McCabe, M.A. Pfeffer, and E. Braunwald C-reactive protein levels and outcomes after statin therapy N. Engl. J. Med. 352 2005 20 28 (Pubitemid 40075677)
23. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N. Engl. J. Med. 342 2000 836 843 (Pubitemid 30165206)
24. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 340 1999 115 126 (Pubitemid 29054847)
25. N.P. Sahu, S.B. Mahato, S.K. Sarkar, and G. Poddar Triterpenoid saponins from Gymnema Sylvestre Phytochemistry 41 1996 1181 1185
26. T. Sawamura, N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, and T. Masaki An endothelial receptor for oxidized low-density lipoprotein Nature 386 1997 73 77 (Pubitemid 27130922)
27. T. Sugiura, Y. Dohi, H. Takase, S. Yamashita, S. Tanaka, and G. Kimura Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects Vasc. Health Risk Manag. 7 2011 475 482
28. P.E. Szmitko, C.H. Wang, R.D. Weisel, J.R. de Almeida, T.J. Anderson, and S. Verma New markers of inflammation and endothelial cell activation: part I Circulation 108 2003 1917 1923 (Pubitemid 37296533)
29. M. Torzewski, C. Rist, R.F. Mortensen, T.P. Zwaka, M. Bienek, J. Waltenberger, W. Koenig, G. Schmitz, V. Hombach, and J. Torzewski C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis Arterioscler Thromb. Vasc. Biol. 20 2000 2094 2099
30. S.J. Tsai, and M.C. Yin Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells J. Food Sci. 73 2008 H174 H178
31. P.M. Vanhoutte, H. Shimokawa, E.H. Tang, and M. Feletou Endothelial dysfunction and vascular disease Acta Physiol. (Oxf.) 196 2009 193 222
32. S. Verma, M.V. Badiwala, R.D. Weisel, S.H. Li, C.H. Wang, P.W. Fedak, R.K. Li, and D.A. Mickle C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis J. Thorac. Cardiovasc. Surg. 126 2003 1886 1891 (Pubitemid 38020747)
33. S. Verma, M.R. Buchanan, and T.J. Anderson Endothelial function testing as a biomarker of vascular disease Circulation 108 2003 2054 2059 (Pubitemid 37337577)